Abbott Expands Medicare Assistance Program To Include $5 Synthroid Scripts
This article was originally published in The Pink Sheet Daily
Executive Summary
The program will be available to low-income Medicare drug card members who exhaust their $600 annual credit. Abbott’s program already offers Humira free of charge and will be expanded to include chronic condition drugs for $12 per monthly script and Synthroid for $5 per month.
|
Abbott will provide its levothyroxin product Synthroid to low-income Medicare-approved drug discount card members for $5 per monthly prescription. The company said May 19 that it is expanding its Medicare Assistance Program, which already provides Abbott's rheumatoid arthritis therapy Humira free of charge to low-income Medicare-eligible patients. In addition to Humira and Synthroid, MAP will offer other Abbott products used to treat chronic conditions for $12 per monthly prescription. Medicare card enrollees who exhaust their $600 annual drug credit will be eligible for the MAP prices. The company is seeking to partner with endorsed card sponsors to provide the benefit. Other drug manufacturers offering assistance to beneficiaries who use up the $600 credit include Merck, Novartis and Johnson & Johnson (1 (Also see "Merck Low-Income Assistance Deals Reached With Most Medicare Rx Card Sponsors" - Pink Sheet, 28 Apr, 2004.)). - Scott Steinke |